2nd Circ. Agrees To Speed Actavis Product-Hopping Hearing
The Second Circuit agreed Monday to hear Actavis PLC's appeal of an injunction forcing the company to continue making an older version of dementia treatment Namenda as soon as possible and...To view the full article, register now.
Already a subscriber? Click here to view full article